Pharmacovigilance deep dive: risk minimisation measures
European Pharmaceutical Review
SEPTEMBER 2, 2022
RMMs aim to optimise the safe and effective use of medical products in clinical practice by improving their risk-benefit balance. She has worked with regulatory agencies and pharmaceutical companies for over 10 years. Before that she has been an independent scientific advisor. About the author.
96 
Let's personalize your content